RA CAPITAL MANAGEMENT, L.P. - 14 Jun 2021 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role: Director, 10%+ Owner
Signature: /s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol: HOWL
Transactions as of: 14 Jun 2021
Net transactions value: +$4,129,398
Form type: 4
Filing time: 16 Jun 2021, 16:58:34 UTC
Previous filing: 10 Jun 2021
Next filing: 16 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HOWL	Common Stock	Purchase	$3,902,201	+306,055	+7.7%	$12.75	4,274,638	14 Jun 2021	See footnotes	F1, F2, F7
transaction	HOWL	Common Stock	Purchase	$103,056	+7,958	+0.19%	$12.95	4,282,596	15 Jun 2021	See footnotes	F3, F4, F7
transaction	HOWL	Common Stock	Purchase	$124,140	+9,285	+0.22%	$13.37	4,291,881	16 Jun 2021	See footnotes	F5, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $12.56 to $12.86; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
F2	These securities include 3,830,813 shares held directly by RA Capital Healthcare Fund, L.P. (the "Fund") and 443,825 shares held by RA Capital Nexus Fund II, L.P. ("the Nexus Fund II")
F3	This transaction was executed in multiple trades at prices ranging from $12.53 to $13.00; the price reported above reflects the weighted average purchase price.
F4	These securities include 3,838,771 shares held directly by the Fund and 443,825 shares held by the Nexus Fund II.
F5	This transaction was executed in multiple trades at prices ranging from $12.92 to $13.50; the price reported above reflects the weighted average purchase price.
F6	These securities include 3,848,056 shares held directly by the Fund and 443,825 shares held by the Nexus Fund II.
F7	RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund II. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.